-

Robbins LLP is Investigating Allegations that the Officers and Directors of Portillo’s Inc. (PTLO) Violated Securities Laws and Breached Fiduciary Duties to Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Portillo’s Inc. (NASDAQ: PTLO) to determine whether certain Portillo’s Inc. officers and directors violated securities laws and breached fiduciary duties to shareholders. Portillo's Inc. owns and operates fast casual restaurants in the United States.

Robbins LLP is Investigating Allegations that the Officers and Directors of Portillo’s Inc. (PTLO) Violated Securities Laws and Breached Fiduciary Duties to Shareholders

Share

On August 5, 2025, Portillo’s reported second quarter 2025 financial results. Although the Company maintained its target of 12 new restaurants and same-restaurant sales growth of 1% to 3%, Portillo’s reduced its fiscal 2025 revenue growth target and lowered its adjusted EBITDA growth expectations. Portillo’s also disclosed that same-restaurant sales increased only 0.7% during the quarter, while transactions declined 1.4%.

Then, on September 10, 2025, Portillo’s announced a business update and strategic reset. Among other things, Portillo’s disclosed that it expected third quarter same-restaurant sales to decline between 2.0% and 2.5%. The Company also cut its fiscal 2025 unit-growth target from 12 new restaurants to 8 new restaurants, lowered its same-restaurant sales outlook from growth of 1% to 3% to a decline of 1% to 1.5%, reduced its restaurant-level adjusted EBITDA margin target, and lowered its adjusted EBITDA outlook. Following these disclosures, Portillo’s stock price declined sharply.

What Now: If you lost money in your investment of Portillo’s Inc., contact Robbins LLP for more information about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas, Jr.
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Portillo’s Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:PTLO

Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Wise Group plc Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Wise Group plc (NASDAQ: WSE) securities between May 11, 2026 and July 23, 2026 (the "Class Period").The complaint alleges that Wise and certain of its senior executives violated the federal securities laws by making materially false and/or misleading statements regarding the Company's anti-money laundering compliance, a...

Shareholder Alert - Robbins LLP Informs Investors of the Capricor Therapeutics, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026 (the "Class Period").The lawsuit alleges that Capricor Therapeutics misled investors regarding the path to FDA approval for its lead product candidate Deramiocel, a cell therapy to address cardiac and skeletal muscle compli...

Shareholder Alert - Robbins LLP Informs Investors of the Bloom Energy Corporation Class Action Lawsuit 

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Bloom Energy Corporation (NYSE: BE) securities between February 27, 2025 and July 8, 2026 (the "Class Period").Bloom Energy designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation in the United States and internationally. Scandium is a rare earth metal used as a dopant to st...
Back to Newsroom